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Abstract
Retroviruses have evolved multiple strategies to direct the synthesis of a complex proteome from
a single primary transcript. Their mechanisms are modulated by a breadth of virus-host
interactions, which are of significant fundamental interest because they ultimately affect the
efficiency of virus replication and disease pathogenesis. Motifs located within the untranslated
region (UTR) of the retroviral RNA have established roles in transcriptional trans-activation, RNA
packaging, and genome reverse transcription; and a growing literature has revealed a necessary role
of the UTR in modulating the efficiency of viral protein synthesis. Examples include a 5' UTR post-
transcriptional control element (PCE), present in at least eight retroviruses, that interacts with
cellular RNA helicase A to facilitate cap-dependent polyribosome association; and 3' UTR
constitutive transport element (CTE) of Mason-Pfizer monkey virus that interacts with Tap/NXF1
and SR protein 9G8 to facilitate RNA export and translational utilization. By contrast, nuclear
protein hnRNP E1 negatively modulates HIV-1 Gag, Env, and Rev protein synthesis. Alternative
initiation strategies by ribosomal frameshifting and leaky scanning enable polycistronic translation
of the cap-dependent viral transcript. Other studies posit cap-independent translation initiation by
internal ribosome entry at structural features of the 5' UTR of selected retroviruses. The retroviral
armamentarium also commands mechanisms to counter cellular post-transcriptional innate
defenses, including protein kinase R, 2',5'-oligoadenylate synthetase and the small RNA pathway.
This review will discuss recent and historically-recognized insights into retrovirus translational
control. The expanding knowledge of retroviral post-transcriptional control is vital to
understanding the biology of the retroviral proteome. In a broad perspective, each new insight
offers a prospective target for antiviral therapy and strategic improvement of gene transfer vectors.
Introduction
Translation of mRNA is a multi-step process essential to
all life. The ability of an organism to regulate mRNA trans-
lation represents a rapid, potent and strategic mechanism
to control gene expression. Defects in translational regula-
tion can be deleterious to survival. Three phases of trans-
lation include initiation, elongation and termination,
with initiation considered the rate-limiting step. Accord-
ing to the ribosome scanning model of initiation, the
mRNA template becomes activated for translation upon
recognition of the 7-methyl-guanosine cap by eIF4E cap-
binding protein, which complexes with other cytoplasmic
initiation factors including eIF4G and eIF4A and eIF4B
[1,2]. The 40S ribosomal subunit associates with eIF3 and
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the ternary complex (eIF2, GTP, Met-tRNA). This 43S
charged ribosome complex joins the activated mRNA and
scans in a 5'-3' direction until an initiator AUG codon in
appropriate Kozak consensus context is detected ([1,3]).
The 60S ribosomal subunit joins the complex to form the
80S complex and translation elongation ensues (for gen-
eral translation review, see [2]). Transcripts containing a
short (<100 nt), relatively unstructured 5' untranslated
region (UTR) are generally good candidates for efficient
ribosome scanning [4]. Conversely, transcripts that con-
tain a longer and highly structured (free energy < -50 Kcal/
mol) 5' UTR are less efficiently scanned [4]. The structural
features of 5' UTR, and possibly features of the ribonucle-
oprotein complex (RNP), impede ribosome scanning and
reduce the efficiency of translation initiation. Retrovirus
proteins are synthesized from capped transcripts that uni-
formly contain long, highly structured 5' UTRs (Figure 1).
Given this inhibitory characteristic, alternative mecha-
nisms are expected to govern retrovirus translation. Inves-
tigation of mRNA translation in the retroviral model
system has informed our understanding of virus-host
interactions important for virus replication. These insights
have also informed our understanding of specialized
mechanisms that modulate translation of complex host
cell mRNA templates.
A dual fate for unspliced retroviral mRNA: translation, 
encapsidation, or both?
In the cytoplasm, the retroviral primary transcript (pre-
mRNA) plays a dual role as unspliced mRNA template for
translation and as genomic RNA that is encapsidated into
assembling virions [5]. The RNA packaging signal in the 5'
UTR of retroviral mRNA represents a pendulum that bal-
ances these possible fates of the genome-length RNA [5].
Results of in vitro translation assays determined that Gag
can modulate translation of a reporter RNA that contains
the HIV-1 5' UTR [6]. The translational output of the tran-
script was increased in response to low concentrations of
Gag and reduced in response to high concentrations of
Gag. Similar trends were observed in transient transfec-
tion assays. The results suggested bimodal modulation of
translation by interaction between Gag and the HIV-1 5'
UTR. The implicit mechanism is that Gag binds to the 5'
RNA packaging signal and facilitates genome encapsida-
tion at the expense of translation (Table 1) [6].
A long-standing issue in retrovirus biology is whether or
not the processes of gag mRNA translation and virion pre-
cursor RNA encapsidation are mutually exclusive [5]. The
take-home message differs between retroviruses. For
example, HIV-2 has been shown to encapsidate RNA co-
translationally [7], while murine leukemia virus (MLV)
produces two functionally distinct pools of mRNA to be
used for either translation or virion assembly [8,9]. In the
case of HIV-1, unspliced RNA can be used interchangeably
for translation and virion assembly [9,10]. In distinction
from HIV-2, translation is not a prerequisite to qualify
unspliced HIV-1 RNA for packaging into virions [10].
LeBlanc and Beemon used translation-dependent non-
sense mediated decay (NMD) as an innovative approach
to evaluate this issue for Rous sarcoma virus (RSV) [11].
Their study evaluated RSV molecular clones that contain
artificial pre-mature termination codons (PTC). The
experiments determined that unspliced PTC-containing
RSV RNA, which is a substrate for translation-dependent
NMD, could be packaged into virions. A follow-up study
in the context of the authentic provirus determined that
RSV utilizes a 3' UTR RNA stability element to evade NMD
and ensure appropriate levels of gag mRNA for virion pro-
tein synthesis [12]. The finding that unspliced RSV tran-
script can be a substrate for both translation and
packaging into virions indicated that these processes are
not mutually exclusive in this alpharetrovirus. A compre-
hensive review of the relationship between gag translation
and virion precursor RNA packaging is presented else-
where [5].
Potential for alternative translation initiation
The 5' UTR of retroviral gag pre-mRNA contains a collec-
tion of highly conserved cis-acting sequences required for
several steps in virus replication. For instance, the HIV-1
5' UTR contains the Tat trans-activation response element
(TAR), primer binding site, genome dimerization signal,
5' splice site and a packaging signal [13]. Because some of
these motifs are upstream of the 5' splice site, they are
maintained within the 5' UTR of the ~30 alternatively
spliced HIV-1 transcripts [14,15]. This proximal section of
the 5' UTR has been shown to inhibit ribosome scanning
and translation initiation of a reporter RNA [14-18]. In
the context of the virus, ligation of the 5' exon to various
distal exons produces additional species of complex 5'
UTRs that are ~350 to 775 nucleotides in length (Figure
1). These long UTRs often contain AUG or CUG
sequences upstream of the authentic initiator codon
[19,20] (Figure 1), which interfere with translation initia-
tion at the appropriate AUG [21]. Another complicating
feature is that authentic initiator codons often are located
within poor Kozak consensus sequences, which may pro-
vide another regulatory feature that modulates expression
of the viral proteome (reviewed in [22]). For example, a
weak Kozak sequence surrounding the HIV-1 vpu AUG
promotes translation of the downstream env gene, a proc-
ess referred to as leaky scanning [14,23]. The inhibitory
features found in the HIV-1 5' UTR are also represented in
all other retroviruses, as summarized for human T cell
leukemia virus type 1 (HTLV-1), mouse mammary tumor
virus (MMTV), and spleen necrosis virus (SNV) in Figure
1[15,24-26]. In spite of the multiple challenges to effi-Retrovirology 2009, 6:8 http://www.retrovirology.com/content/6/1/8
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Figure 1 (see legend on next page)
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cient cap-dependent translation initiation, sufficient ret-
rovirus protein production prevails.
The potential dichotomy of mechanisms governing trans-
lation initiation of retroviruses is a topic of some contro-
versy. The use of cap-independent initiation at an internal
ribosome entry sequence (IRES) has been proposed to cir-
cumvent inhibition of scanning ribosomes by the com-
plex 5' UTR. Originally identified in the Picornaviridae,
which includes poliovirus and encephalomyocarditis
virus (EMCV), the IRES promotes recruitment of the 43S
ribosome independently of cap-binding [27-29]. Tran-
scripts of the Picornaviridae lack a 5' cap and provide cyto-
plasmic viral enzymes to inactivate factors including
eIF4E, eIF4G and poly(A) binding protein (PABP) [30-
32]. Consequently, picornavirus transcripts are reliant on
an IRES to initiate viral protein synthesis [27,28,33].
By contrast, transcripts of the Retroviridae are considered
to bear a 5' cap and therefore IRES-dependent initiation is
not necessarily critical. In support of this idea, translation
of the avian spleen necrosis virus is reduced when cap-
dependent translation is inhibited by infection with
EMCV [34]. Nevertheless, the search for IRES activity in
the Retroviridae has been extensive with IRES-like activity
proposed for at least six retroviruses, including HIV-1 and
HIV-2 [35-37], simian immunodeficiency (SIV) [38], RSV
[39], and murine leukemia viruses (Friend and Moloney
strains, F-MLV and MoMLV, respectively) [40-42], and
Harvey murine sarcoma virus (HMSV) [43] (Table 1 and
reviewed in [22]). Studies to identify internal initiation in
isolated viral UTR segments have primarily utilized the
transfection of bicistronic reporter plasmids. A caveat to
this approach is false-positive IRES activity attributable to
cryptic promoter activity or splicing of the test sequence.
A case study of bicistronic reporter plasmids that
employed extensive RNA analysis determined that 5' UTR
sequences of HTLV-1, REV-A, or SNV produced multiple
transcripts that correlated with false-positive IRES activity
[34]. The false-positive activity was validated by the obser-
vation that transfection of homologous in vitro tran-
scribed RNA did not recapitulate IRES activity. A possible
caveat is that the transfected RNAs may fail to interact
with necessary IRES-transacting factors (ITAFs) in the
nucleus. An alternative approach to measure HIV-1 IRES
employed poliovirus infection to inhibit cap-dependent
translation initiation. The results determined that HIV-1
Gag protein synthesis is sustained from a heterologous
reporter plasmid during poliovirus infection [36]. Unex-
pectedly, the putative IRES activity was conferred by
sequences downstream of the gag translation initiation
codon, rather than the 5' UTR. In summary, utilization of
internal ribosome entry at retroviral IRES remains a con-
troversial subject, and conditional IRES activity is an
intriguing possible explanation for the disparate results.
An alternative scenario is that features of the complex 5'
UTR direct mechanistically uncharacterized virus-host
interactions to modulate cap-dependent initiation. This
scenario and its perspective into the translation of com-
plex cellular mRNAs are discussed in the next section.
Cap-dependent retrovirus translation enhancers
Retroviral RNA interacts with a collection of cellular and
viral co-factors (see Table 2). Three examples of viral RNA-
host protein interactions that facilitate retroviral transla-
tion will be discussed. These interactions offer the model
that an active remodeling process balances appropriate
viral RNA translation with efficient trafficking for RNA
packaging into assembling virions.
Many retroviruses utilize a 5' terminal post-transcriptional control 
element responsive to cellular RNA helicase A
While cap-independent initiation at an IRES is one
approach for viral mRNAs to overcome barriers to ribos-
ome scanning, another is represented by the post-tran-
scriptional control element (PCE) (Table 1). Similar to the
IRES, the PCE initially was identified in viral mRNA and
subsequently in cellular transcripts [34,44-47]. Accord-
ingly, study of retroviral PCEs provides a window into
translation control of complex cellular mRNAs [46].
PCE is a redundant stem-loop RNA structure that was ini-
tially identified in the 5' UTR of avian spleen necrosis
virus (SNV) and subsequently in a growing collection of
Properties of selected retrovirus transcripts Figure 1 (see previous page)
Properties of selected retrovirus transcripts. HIV-1, human T-cell leukemia virus type 1 (HTLV-1), mouse mammary 
tumor virus (MMTV), and spleen necrosis virus (SNV) transcripts are depicted, including predominant unspliced and spliced 
mRNA species. Numbering is in reference to the first nucleotide of R, the RNA start site, as +1. Red numbers below each 
mRNA indicate the nucleotide position of exon junctions. Dashed lines denote introns. AUG indicates translation initiation 
codon, and black numbers indicate AUG nucleotide positions. The unused AUG in bicistronic transcripts is depicted in gray 
parentheses. Predicted free energy values are derived from possible RNA structure calculated by Zuker mfold software ver-
sion 3.2. The number of AUG or CUG codons upstream of the authentic AUG initiator codon is indicated in the far-right col-
umn. 7 mG, 5' RNA cap structure; (A)x, poly A tail. HIV-1 information was derived from [15]; HTLV-1 information was derived 
from [24] and GenBank NC_001436; MMTV information was derived from GenBank U40459, DQ223969, and [25]; SNV 
information was derived from reference sequence pPB101 [26].Retrovirology 2009, 6:8 http://www.retrovirology.com/content/6/1/8
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Table 1: Retrovirus mechanisms to modulate protein synthesis
Mechanism Examples of viruses reported to utilize 
mechanisma
Effect on translation
Internal Ribosome Entry Site
(IRES)
HIV-1, HIV-2, SIV, HMSV, MLV, RSV Cap-independent translation enhancer. 
Ribosomes plus a subset of initiation factors 
internally initiate translation independently of a 
5' 7-methylguanosine cap.
Post-transcriptional control element 
(PCE)
SNV, REV-A, HTLV-1, BLV, MPMV, FeLV,
HIV-1, HFV
Novel 5' terminal cap-dependent translation 
enhancer. Specific interaction with RNA 
helicase A facilitates polysome loading and 
efficient viral protein production. PCE is not an 
IRES.
Leaky scanning HIV-1 Readthrough of upstream AUG codons allows 
translation initiation of a downstream gene (i.e. 
vpu and env).
Ribosome reinitiation RSV Short upstream open reading frames present in 
5' leader RNA attenuate translation initiation at 
the authentic gag-pol AUG. Effect is dependent 
on distance from AUG.
Frameshifting Most retroviruses Stimulatory signal and slippery sequence 
present in mRNA induce ribosome pausing and 
a -1 reading frame change. Results in translation 
of gag-pol open reading frame to produce 
reverse transcriptase and other enzymatic 
proteins.
Termination codon readthrough FeLV, MLV Termination codon of gag open reading frame 
is read as glutamate. Results in translation of 
gag-pol open reading frame to produce reverse 
transcriptase and other enzymatic proteins.
Ribosome shunt Not determined Scanning ribosome bypasses mRNA structural 
motif to reach AUG.
Gag-gag mRNA interaction RSV, HIV-1 Gag protein binds to the 5' UTR of gag mRNA 
and attenuates translation efficiency.
Cis-acting repressive sequences/
inhibitory sequences
(CRS/INS)
HIV-1 AU-rich sequences present in gag, pol and env 
mRNA bind cellular proteins involved in mRNA 
metabolism and translation. This association 
represses cytoplasmic expression of the 
mRNA.
Rev HIV-1 Viral regulatory protein recognizes intronic cis-
acting Rev response element (RRE) and 
counteracts repression by INS/CRS. Trans-
activates nuclear export, with coincide 
increases in mRNA stability and polysome 
loading that result in robust viral protein 
production. HTLV-1 Rex/RxRE and MMTV 
Rem/RmRE activity activate nuclear export and 
may likewise enhance translational output.
a BLV, bovine leukemia virus; FeLV, feline leukemia virus; HFV, human foamy virus; HMSV, Harvey murine sarcoma virus; HTLV-1, human T-cell 
leukemia virus type 1; MLV, murine leukemia virus; MPMV, Mason-Pfizer monkey virus; REV-A, reticuloendotheliosis virus strain A; RSV, Rous 
sarcoma virus; SIV, simian immunodeficiency virus; SNV, spleen necrosis virus.Retrovirology 2009, 6:8 http://www.retrovirology.com/content/6/1/8
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Table 2: Retrovirus:host interactions involved in retroviral translation control
Host factor Examples of interacting virusa Effect on translation
Interacts with retrovirus 
protein & RNA
Protein kinase R (PKR) HIV-1, HTLV-1 HIV-1 Tat reduces PKR 
autophosphorylation. Tat and 
eIF2α compete as substrates of 
PKR. High levels of HIV-1 TAR 
RNA or HTLV-1 RxRE inhibit PKR 
autophosphorylation.
Small RNA pathway components
(Dicer & Drosha)
PFV, HIV-1 PFV Tas and HIV-1 Tat act as RNA 
silencing suppressors that combat 
the antiviral effect of small RNA 
pathway. Also miRNAs may be 
encoded by retroviruses that 
downregulate host antiviral 
defense.
Interacts with retrovirus RNA TAR RNA binding protein (TRBP) HIV-1 Binding of TRBP to HIV-1 TAR 
RNA results in increased HIV-1 
transcription and translation.
2', 5'-oligoadenylate-synthetase/
RNaseL
HIV-1, HTLV-1 HIV-1 5' UTR RNA binds 2-5OAS 
resulting in RNAseL activity in vitro. 
HIV-1 infection is associated with 
reduced interferon production and 
reduced 2-5A:RNAseL binding, 
allowing HIV-1 mRNA to evade 
cleavage by RNaseL. HTLV-1 RxRE 
activates 2-5OAS in vitro.
RNA helicase A
(RHA or DHX9)
SNV, REV-A, HTLV-1, MPMV, 
HFV, FeLV, BLV, HIV-1
RHA binds PCE mRNA leading to 
increased polysome association 
and efficient protein synthesis.
9G8 MPMV In overexpression experiments, 
hyper-phosphorylated 9G8 binds 
constitutive transport element-
containing reporter mRNA 
resulting in increased polysome 
accumulation and protein 
synthesis.
Sam68, SLM-1, SLM-2 HIV-1, HTLV-1, EIAV, MPMV Sam68, SLM-1 and SLM-2 act 
synergistically with HIV-1 Rev, 
HTLV-1 Rex and EIAV ERev to 
facilitate expression and proper 
cytoplasmic localization of RRE-
containing mRNA. Sam68 also 
enhances translation of mRNA 
containing the MPMV constitutive 
transport element.
hnRNP E1 HIV-1 hnRNPE1 binds HIV-1 mRNA at 
the exon splicing silencer in Rev 
exon (ESSE) and reduces Gag, Env, 
and Rev protein production.
eRF1 MLV MLV reverse transcriptase binds 
eRF1 promoting readthrough of 
the gag termination codon to 
produce proteins encoded by gag-
pol.Retrovirology 2009, 6:8 http://www.retrovirology.com/content/6/1/8
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retroviruses across the metazoa including Mason-Pfizer
monkey virus (MPMV), human foamy virus (HFV), retic-
uloendotheliosis virus strain A (REV-A), human T-cell
leukemia virus type 1 (HTLV-1), feline leukemia virus
(FeLV), bovine leukemia virus (BLV) [34,44,45,47-49]
and HIV-1 (Bolinger and Boris-Lawrie, unpublished
data). A significant step toward understanding the control
mechanism enforced by PCE was the discovery that cellu-
lar RNA helicase A (RHA or DHX9) specifically associates
with PCE and is critical for robust translation of PCE-con-
taining mRNAs [46] (Table 2). RHA is a multifunctional
DEIH box helicase and RNA binding protein, and deregu-
lation of RHA has been associated with various cancers
and autoimmune disease [50-53]. In addition, RHA
knockout in mice is embryonic lethal [54]. Roles for RHA
in transcription and pre-mRNA splicing have been charac-
terized, and new evidence indicates a role for RHA in load-
ing of guide-strand siRNA onto the RNA interference
silencing complex (RISC) [55]. Hartman et al. determined
that RHA interacts with PCE-containing mRNAs in the
nucleus and cytoplasm, and postulated that RHA contrib-
utes to RNA/RNP remodeling that facilitates polyribos-
ome association [46]. Upon RHA downregulation, PCE-
containing mRNAs still accumulate in the cytoplasm,
however they are translationally-silent and possibly
sequestered in RNA storage granules. Likewise, non-func-
tional PCE mutant RNAs accumulate in the cytoplasm;
these transcripts lack efficient interaction with RHA and
are poorly translated [44,46-48]. Experiments utilizing
SNV PCE-HIV gag reporter RNA determined that RHA
downregulation specifically decreased the rate of Rev/
RRE-independent Gag protein production, independently
of a change in global protein or RNA synthesis [46]. The
effect of RHA on Gag production occurs at the post-tran-
scriptional level because quantitative RNA analyses
detected no significant change in steady-state gag mRNA
levels or nuclear/cytoplasmic distribution.
The PCE/RHA RNA switch is also operative in human ret-
roviruses. The R and U5 sequences of the HIV-1 and
HTLV-1 5' LTR function coordinately to confer RHA-
dependent PCE activity (Bolinger, Sharma, Singh, Boris-
Lawrie, unpublished data). Experiments with HTLV-1 pro-
virus indicated that downregulation of endogenous RHA
significantly reduced polysome accumulation of HTLV-1
gag mRNA from 75% to ~10% [34]. Control experiments
determined that RHA downregulation was specific to
HTLV-1 gag and did not affect gapdh RNA or global cellu-
lar translation [34,46]. Experiments with HIV-1 provirus
indicated that RHA downregulation reduces HIV-1 gag
translation (Bolinger, Sharma, Singh, Boris-Lawrie,
unpublished data). In summary, RHA/PCE operates a 5'
proximal RNA switch that is critical for translation of
many retroviruses (Tables 1 and 2).
Nuclear interaction with host proteins facilitates retrovirus translation
The post-transcriptional processes of mRNA splicing,
export, and translation are mechanistically linked and
unspliced host pre-mRNA is typically a poor substrate for
nuclear export or cytoplasmic translation [56]. However,
retroviruses utilize the unspliced pre-mRNA as template
for synthesis of essential structural and enzymatic pro-
teins. Retroviruses have therefore evolved specialized
mechanisms to ensure efficient export and translation
independently of cellular default controls. Cis-acting RNA
elements and interactive partners, such as HIV-1 Rev
responsive element (RRE) and Rev, HTLV-1 Rex respon-
sive element (RxRE) and Rex, or Mason-Pfizer monkey
(MPMV) virus constitutive transport element (CTE) are
necessary for efficient nuclear export of unspliced viral
pre-mRNA. While HIV-1 RRE or HTLV-1 RxRE interact
with Rev or Rex to connect to the CRM1 export receptor,
CTE of the genetically simpler MPMV directly interacts
with the Tap/NXF1 nuclear export receptor [57-60].
Another nuclear protein, 9G8, is recruited to the MPMV
CTE during transcription; subsequent dephosphorylation
triggers recruitment of Tap/NXF1 [58,61-65]. The associa-
tion of Tap/NXF1 with CTE is critical for the export of
intron-containing MPMV mRNA into the cytoplasm,
where it remains associated with 9G8 [59,60].
In a particular cellular environment CTE was shown to
enhance the translational efficiency of HIV-1 gag-pol
mRNA in conjunction with the PCE located in the MPMV
5' LTR [66]. The synergistic effect of PCE and CTE on pro-
tein production was observed in monkey COS cells, but
not human 293 cells. Translation enhancement was also
dependent on the presence of a retroviral promoter,
which posited co-transcriptional recruitment of a cellular
factor that is more available in Cos cells than 293 cells.
Consistent with this idea, overexpression of Tap/NXF1
increased production of the Gag reporter protein by 30-
fold in 293 cells independently of an increase in total gag
mRNA abundance or cytoplasmic accumulation. The
increase in translational utilization of the RNA was con-
ferred specifically by CTE, since reporters containing PCE
but not CTE, were not affected by Tap/NXF1 overexpres-
sion. These results provided an example of nuclear virus-
host interaction that modulates translation.
In a separate study, splicing regulatory protein 9G8 was
identified as a cellular protein that increases cytoplasmic
a BLV, bovine leukemia virus; EIAV, equine infectious anemia virus; FeLV, feline leukemia virus; HFV, human foamy virus; HTLV-1, human T-cell 
leukemia virus type 1; MLV, murine leukemia virus; MPMV, Mason-Pfizer monkey virus; REV-A, reticuloendotheliosis virus strain A; SNV, spleen 
necrosis virus.
Table 2: Retrovirus:host interactions involved in retroviral translation control (Continued)Retrovirology 2009, 6:8 http://www.retrovirology.com/content/6/1/8
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utilization of the HIV-1 gag-pol-CTE reporter mRNA [66].
Overexpression of 9G8 in 293T cells produced a 10-fold
increase in Gag protein production from the reporter RNA
[60]. The overexpression of 9G8 did not alter cytoplasmic
accumulation of the reporter RNA but increased polyri-
bosome association by 10-fold. Ribosomal profiles and
immunoblots indicated that hyperphosphorylated 9G8
was associated with high molecular weight complexes that
were sensitive to EDTA treatment, indicating that 9G8
likely associated with polyribosomes and not other heavy
complexes (referred to as "pseudo-polysomes" [67]).
These results bolstered the recent realization that splicing
regulatory proteins provide functional linkage between
multiple steps of post-transcriptional gene regulation, and
that the linkage is co-opted during retrovirus replication
[68,69].
Sam68 (Src-associated in mitosis 68) is another host pro-
tein that increases cytoplasmic utilization of CTE-contain-
ing mRNA [70]. Sam68 has been shown to functionally
synergize with Rev-like proteins of complex retroviruses to
bolster viral post-transcriptional gene expression [71,72].
Sam68:RNA interaction in the nucleus has been shown to
facilitate the association of viral RNA with translation
machinery in the cytoplasm, resulting in enhanced pro-
tein production [73]. Sam68 activity is addressed in more
detail below.
hnRNP E1 negatively influences HIV-1 protein production
RHA, 9G8, and Sam68 are examples of nucleocytoplasmic
shuttling proteins that promote efficient viral protein pro-
duction. By contrast, hnRNP E1 provides an antagonistic
effect on HIV-1 protein synthesis. hnRNP E1 is a nuclear
protein that interacts with the HIV-1 exon splicing silencer
in Rev exon (ESSE3) [74]. Contrary to the name, this inter-
action is not associated with significant change in viral
RNA splicing. Instead, overexpression of hnRNP E1
caused a substantial decrease in Gag (p55 and p24), Env
(gp160/gp120), and Rev production. Fractionation assays
indicated that the decreased level of Rev protein remained
sufficient for export of HIV-1 Rev-dependent env RNA. A
complementary experiment utilizing siRNA downregula-
tion of endogenous hnRNP E1 recapitulated a significant
change in Gag and Env protein without observable effect
on RNA abundance or splicing. These results indicated
that hnRNP E1 negatively affects HIV-1 translation. A pos-
sible mechanism is that hnRNP E1 blocks the association
of the 60S ribosome with the 43S initiation complex once
the initiation codon is reached, as has been observed for
hnRNP E1 and r15-LOX mRNA [75]. Other feasible expla-
nations are the disruption of another step in the transla-
tion process or the reduced stability of the nascent
polypeptide.
Initiation and beyond: Retrovirus protein production is 
reliant on ribosome frameshifting and leaky scanning
Retroviruses employ economical strategies of post-tran-
scriptional control that culminate in expression of multi-
ple viral open reading frames from a relatively small (~10
kb) genome. The strategies include alternative translation
initiation, modulation of elongation and polypeptide ter-
mination.
Control of translation by RNA localization and leaky scanning
For genetically simple retroviruses, inefficient splicing
produces Gag, Gag-Pol and Env open reading frames on
separate transcripts. Genetically complex retroviruses,
such as HIV-1, employ alternative splicing to produce
open reading frames for regulatory and accessory proteins
on additional transcripts (Figure 1) [14,15]. As summa-
rized above, the 5' UTR of both unspliced and spliced ret-
roviral transcripts contain features that impede ribosomes
scan and alternative mechanisms are expected to choreo-
graph viral protein production (reviewed in [22]). An eco-
nomic strategy of leaky scanning provides HIV-1 Vpu and
Env protein synthesis from a single bicistronic vpu-env
mRNA [76]. Schwartz and colleagues demonstrated that
translation of env is reliant on a weak Kozak consensus
surrounding the vpu AUG. As a result, ribosomes scan
past the vpu AUG to reach the env AUG and initiate trans-
lation of env, which is a process referred to as leaky scan-
ning [23]. When the context of the vpu AUG is mutated to
a match a strong Kozak consensus and reduce
readthrough, env translation is abrogated [23]. By con-
trast, a higher level of env translation is achieved upon
mutation of the vpu AUG [77]. Thus, leaky scanning
through the vpu AUG is an important mechanism to
achieve balanced expression of these HIV-1 gene products
and is important for efficient virus replication [76].
A recent study of the 5' UTR of 16 env RNA isoforms pro-
duced by alternative splicing identified that production of
Vpu is largely dependent on inclusion of exons that
exclude the upstream rev AUG [78] These results rein-
forced the important role of the upsteam AUG in temper-
ing env translation initiation [78]. Anderson and
colleagues found that the four env mRNA isoforms con-
taining exon 5E (isoforms 1,5,8, and 13) produced
approximately four-fold more Vpu accessory protein in
comparison to the rev AUG-containing isoforms. Muta-
tion of the rev AUG in env2 increased Vpu production to
a level similar to env1, indicating that initiation at the
upstream rev AUG significantly depletes scanning ribos-
omes to initiate at the vpu initiation codon, consistent
with the leaky scanning mechanism. However, in contrast
to previous studies by Schwartz and colleagues, the pres-
ence of upstream AUGs had little effect on Env synthesis,
suggesting the possibility of translation via a discontinu-
ous scanning mechanism (IRES or ribosome shunt). TheRetrovirology 2009, 6:8 http://www.retrovirology.com/content/6/1/8
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authors showed that the changes in protein expression
were not attributable to aberrant transcripts from cryptic
splicing, promoter activity or differential mRNA stability.
A companion study by Krummheuer and colleagues sug-
gested that a minimal five nucleotide open reading frame
upstream of the vpu AUG acts as a ribosome pausing site,
which is a feature of the ribosomal shunt characterized in
cauliflower mosaic virus [79-84]. The cap-dependent
ribosomal shunt is an intriguing alternative initiation
mechanism that deserves further analysis in retroviruses.
Ribosomal frameshifting during translation elongation
Translation initiation has been studied intensively to
understand mechanisms controlling cellular and viral
protein synthesis. The translation elongation cycle, which
is a closely regulated and high energy consuming process,
also plays a profound role in the regulation of protein syn-
thesis [85]. After initiation, phosphorylated elongation
factors 1A and 1B (eEF1A and eEF1B) mediate amino acyl-
tRNA recruitment to the ribosome A site and GDP/GTP
exchange, respectively. Ribosome translocation occurs
when elongation factor 2 (eEF2) associates with the ribos-
ome and binds GTP to move the tRNA into the ribosome
P site. This translocation results in a one-codon shift of the
ribosome relative to the mRNA. mRNA containing a com-
bination of repetitive sequences, referred to as slippery
sequence, and stable secondary structure can pause ribos-
ome locomotion leading to a mRNA reading frame
change, referred to as programmed frameshift [86-88].
Essential retrovirus enzymatic proteins protease, inte-
grase, and reverse transcriptase are encoded by the pro and
pol genes that are distal to the Gag open reading frame in
the viral unspliced mRNA. For lentiviruses and deltavi-
ruses, the Pro and Pol coding regions are in a different
reading frame than Gag. A -1 ribosome frameshift is nec-
essary for synthesis of the Gag-Pro-Pol polyprotein, which
is self-cleaved by the viral protease during maturation
[87]. HIV-1 requires a single frameshift to produce Gag-
Pol, while other retroviruses, such as HTLV-2, employ two
separate frameshifts to produce Gag-Pro and Gag-Pro-Pol
[89,90]. Frameshifting occurs at an approximate rate of 1
Gag-Pol for every 20 Gag molecules synthesized [25,87].
Disruption of either an upstream heptanucleotide slip-
pery sequence (UUUUUUA in HIV-1) or an RNA stem-
loop pseudoknot structure downstream of the frameshift
site (referred to as the stimulatory signal) [91-93] alters
frameshift efficiency and is deleterious to virus replication
[94]. Recent work has indicated that both the seven nucle-
otides of the slippery sequence and the three preceding
nucleotides are essential to maintain proper Gag-Pol ratio
[95]. Brakier-Gingras and colleagues proposed an elegant
model in which -1 frameshifting involves tRNA interac-
tion with the ribosome at not only the P and A sites, but
also with the E site [95]. Bicistronic reporters were con-
structed containing the HIV-1 seven nucleotide slippery
sequence directly preceded by three nucleotides derived
from the full 10 nucleotide slippery sequence of multiple
viruses, including HTLV-1 and equine infectious anemia
virus (EIAV). The upstream coding region contained
renilla luciferase as a transfection efficiency control and
firefly luciferase reporter downstream of the viral slippery
sequence. Firefly Luciferase protein is observable in the
event of a -1 ribosome frameshift. Results from transiently
transfected 293T cells indicated that maintenance of the
frameshift ratios required the authentic decanucleotide
sequences from each virus. These results implicate that
specific tRNA occupancy at the ribosome E site is impor-
tant for -1 frameshift efficiency.
A similar reporter system was used to study the relation-
ship between frameshifting and the activity of protein
kinase R (PKR) [96]. This study found that inhibition of
PKR activity by transfection of high levels of TAR RNA into
Jurkat T cells or 293T cells resulted in decreased
frameshifting efficiency. This effect occurred whether TAR
was present in the reporter mRNA or expressed in trans
from a separate plasmid. By contrast, activation of PKR by
transfection of low amounts of TAR RNA increased
frameshifting efficiency by 140%. TAR RNA had no effect
on frameshifting after downregulation of PKR by siRNAs
in 293T cells. Furthermore, the introduction of a TAR
mutant deficient in PKR binding had no effect on
frameshifting. The results indicated that TAR-PKR interac-
tion contributes to efficient viral frameshifting. The pro-
posed model is that translation initiation efficiency and
frameshifting are inversely correlated. When the rate of
translation initiation is slow (due to activation of PKR by
TAR), frameshifting occurs at a higher rate because spac-
ing between ribosomes increases and each ribosome
encounters the frameshifting signal. Conversely,
frameshifting decreases when the rate of initiation is
increased because the stimulatory signal does not have
time to refold and ribosomes continue to translate with-
out pausing.
Modulation of translation termination by MLV reverse transcriptase
Translation termination occurs when the cellular release
factor eRF1 recognizes a stop codon and GTP is hydro-
lyzed by eRF3 [97]. eRF1 has a structure similar to tRNA
and is thought to bind the ribosome A site in a similar
fashion to tRNA; it is proposed that stop codon recogni-
tion occurs through anticodon mimicry [98,99]. The hall-
mark enzyme of the retrovirus family, reverse
transcriptase, is encoded by the pol gene and is absolutely
essential for viral replication. For synthesis of infectious
retrovirus, pol RNA is translated by a ribosomal frameshift
at a slippery sequence (as in HIV-1) or by readthrough of
the gag termination codon (as in FeLV and MLV)
[87,100]. In the case of readthrough, a UAG stop codon is
read as glutamine and translation proceeds to generate theRetrovirology 2009, 6:8 http://www.retrovirology.com/content/6/1/8
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Gag-Pol polyprotein [101,102]. A combination of yeast
two-hybrid, in vitro, and in vivo studies by Orlova and col-
leagues demonstrated that MLV reverse transcriptase
binds to eRF1 through a direct protein-protein interaction
that enhances readthrough of the gag stop codon [103].
This interaction appears to be specific to MLV, as HIV-1
reverse transcriptase, which does not require termination
codon readthrough for Pol synthesis, did not bind eRF1.
The interaction of MLV RT with eRF1 allows the RT to self-
regulate translation termination, thereby maintaining an
appropriate ratio of Gag:Gag-Pol protein, which is critical
to generate infectious virus [104].
Retroviral regulatory export proteins Rev, Rex, and Rem 
may moonlight as translation stimulation factors
The HIV-1 post-transcriptional regulatory protein, Rev, is
a 116 amino acid nuclear-cytoplasmic shuttling RNA
binding protein [105-107] that is required for delivery of
genome-length, unspliced RNA to the cytoplasm for sub-
sequent translation and/or packaging into virions [5].
Synonymous loci have been identified in other complex
retroviruses, including HTLV-1 and HTLV-2 Rex/RxRE and
mouse mammary tumor virus (MMTV) Rem/RmRE [108-
111].
Extensive experimentation with reporter plasmids and
HIV-1 provirus has characterized Rev/RRE as a potent
molecular switch that significantly trans-activates cyto-
plasmic accumulation of intron-containing RNAs. In the
absence of Rev, cis-acting inhibitory sequences cause
nuclear retention and low steady-state accumulation of
these RNAs [112-116]. In the presence of Rev, the stability
and nuclear export of RRE-containing transcripts are acti-
vated [117]. In addition to trans-activation of HIV-1
mRNA export, Rev has been identified to promote transla-
tion of RRE-containing mRNA [118,119]. D'Agostino et
al. demonstrated that co-transfection of Rev with gag-RRE
reporter plasmids in HeLa-Tat cells yielded a discordant
relationship between the increase in cytoplasmic RNA and
Gag protein levels. Addition of Rev caused a 4 to 16-fold
increase in cytoplasmic accumulation of reporter RNA
while Gag protein level increased by a discordant 850-
fold. Ribosomal profile analysis indicated an increase in
gag polysome association from 4% to 20% upon addition
of Rev. The results indicated that Rev/RRE activity
increases the cytoplasmic utilization of the Rev-depend-
ent mRNA. A similar conclusion was reached by Arrigo et
al., who transfected lymphoid cells with HIV-1 provirus
that either lacked or contained the Rev open reading
frame [118,120]. The presence of Rev increased polysome
association of gag, vif, vpr, and vpu/env mRNA, indicating
that Rev increases the translational efficiency of Rev-
dependent transcripts. The observation by Cochrane and
colleagues that Rev/RRE activity requires interaction with
newly synthesized RNA [121] is consistent with the theme
that nuclear interactions facilitate cytoplasmic utilization
of retroviral RNA, as discussed above for RHA/PCE and
9GA/CTE.
A translational role for Rev-like proteins encoded by other
retroviruses remains to be investigated in detail. Notably,
study of HTLV-2 Rex-2/RxRE activity measured a 7-to-9
fold increase in cytoplasmic accumulation of gag RNA
that was accompanied by a discordant 130-fold increase
in steady state Gag protein, which is reminiscent of HIV-1
Rev/RRE activity [119,122]. Given the similarity of
domain structure between HIV-1 Rev, HTLV-1 Rex and
MMTV Rem, the conservation of functional activity in
both nuclear export and cytoplasmic translation is an
expectation (Table 2).
Study of the cellular protein Sam68 has produced addi-
tional insights into post-transcriptional control of retrovi-
ral gene expression. Sam68 and Sam68-like proteins SLM-
1 and SLM-2 act synergistically with Rev to increase
expression of RRE-containing mRNAs [73,123]. Synergis-
tic activity is also observed by co-expression of Sam68 and
HTLV-1 Rex or EIAV ERev [124]. Furthermore, C-terminal
truncation of Sam68, which deletes the nuclear localiza-
tion signal, generates an isoform that inhibits Rev activity
and negated the effects of wild type Sam68, SLM-1 or
SLM-2 on HIV-1 gene expression [73,123]. The cytoplas-
mically-restricted Sam68 mutant did not inhibit Rev shut-
tling ability, but changed the cytoplasmic distribution of
RRE-containing unspliced HIV-1 env reporter RNA from a
dispersed pattern to sequestration at the nuclear periph-
ery. Addition of the SV40 large T antigen nuclear localiza-
tion signal to the Sam68 mutant restored proper
distribution of cytoplasmic RRE-RNA. These observations
posited that interaction of Sam68 and RRE in the nucleus
is critical for the target RNA to associate with translation
machinery in the cytoplasm [73]. In sum, results with Rev,
Sam68, RHA, 9G8 and hnRNPE1 echo the theme that
nuclear interactions are important for productive retrovi-
rus translation in the cytoplasm.
Rev/RRE regulation of viral protein production involves
derepression of cis-acting repressive sequences (CRS, also
referred to as instability sequences [INS]) present in HIV-
1 gag, gag-pol, and env mRNA [112,115,125]. When
placed 3' to chloroamphenicol acetyltransferase reporter
gene, AU-rich segments of gag, pol, or env coding regions
substantially reduced reporter gene activity
[112,115,125]. Addition of the Rev responsive element
(RRE) in cis  and Rev protein in trans  alleviated gene
repression. In this reporter system, cytoplasmic accumula-
tion and steady-state RNA levels were relatively unaf-
fected, although the addition of CRS to a different reporter
caused nuclear retention in the absence of Rev [112]. RNA
affinity assays indicated that CRS interacted with cellularRetrovirology 2009, 6:8 http://www.retrovirology.com/content/6/1/8
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splicing factor hnRNPC1 and potentially other undefined
factor(s). The nuclear retention of viral mRNA was attrib-
uted to sequestration in RNA-protein complexes that are
inaccessible for nuclear export [126].
Further study of HIV-1 cis-acting repressive sequences by
Schwartz et al (referred to as INS elements) showed that
AU-rich regions of p17gag transcript decreased mRNA sta-
bility and reduced the steady-state abundance of viral
RNA [115]. Similar to experiments described above, co-
transfection of Rev expression plasmid relieved the inhib-
itory effect of INS on HIV-1 tat-RRE-gag reporter RNA.
Mutations in the INS lead to Rev-independent gene
expression and eliminated the instability phenotype. Mul-
tiple proteins have been identified to bind INS elements,
including hnRNP A1 [127,128], polypyrimidine tract
binding protein (PTB) [127,128], polypyrimidine tract-
binding protein-associated splicing factor (PSF) [129] and
poly(A)-binding protein (PABP) [130]. The binding part-
ners have been postulated to coordinate interrelated steps
in HIV-1 RNA post-transcriptional control. For example,
hnRNP A1 was found to stimulate Rev-dependent mRNA
export [131]; PSF modulates nuclear retention [129]; and
PABP modulates transcript stability [130]. Overexpression
of PSF decreases the abundance of all HIV-1 transcripts,
with the most substantial effect on unspliced and singly
spliced species [129]. Binding of PABP to INS RNA corre-
lated with reduced mRNA stability, which indicated that
PABP association at regions other than the polyA tail
could disrupt or compete the formation of RNP necessary
for efficient translation initiation.
In addition to affecting HIV-1 RNA export and stability,
codon bias that results from the unusually high AU con-
tent of HIV-1 transcripts may attenuate translation. The
presence of rare codons has been demonstrated to induce
ribosome pausing that culminates in RNA turnover
(Reviewed by Hentze and Kulozik [132]). Codon optimi-
zation of HIV-1 env and gag-pol sequences has been
shown to increase viral protein production in human cells
[133,134]. Furthermore, codon optimization of gag-pol
increased RNA abundance and eliminated the require-
ment for Rev/RRE in HIV-1 based vector systems [134].
The observations that codon optimization eliminates
Rev/RRE dependence support a positive role for Rev/RRE
in stability and translation of HIV-1 transcripts.
Although studies have observed CNS/INS to modulate
HIV-1 RNA by different post-transcriptional mechanisms,
the convergent conclusion is that these viral sequences
interact with cellular proteins involved in splicing and
other steps in mRNA metabolism to balance virus protein
production. Furthermore, these studies emphasize that
Rev/RRE is a multifunctional protein/RNA interaction
which can trans-activate the stability of RRE-containing
viral mRNAs, their export from the nucleus, and their
translation in the cytoplasm. The combination of these
roles makes Rev/RRE a strategic regulatory axis in HIV-1
replication.
A balancing act: The ability of retroviruses to elicit or block 
innate host defense pathways
Studies have revealed retrovirus escape from multiple
mechanisms of innate cellular defense and exploitation of
these pathways for benefit of the virus. Strategies for
exploitation are enacted by viral RNA elements, such as
the HIV-1 Tat trans-activation response element (TAR), or
through direct interaction of viral proteins (such as HIV-1
Tat) with innate defense proteins. Here we discuss retrovi-
rus interaction with: i) the interferon-induced protein
kinase R (PKR) pathway; ii) the interferon-induced 2'5'-
oligoadenylate synthesis pathway; and iii) the small RNA
pathway (Figure 2). Investigation has determined the
interplay between virus and cellular defense mechanisms
to be highly dependent on virus concentration and has
uncovered elegant stratagies that temporally control these
interactions for the overall benefit of virus survival.
HIV-1 vs. the PKR pathway
HIV-1 TAR is a highly-conserved stable RNA stem loop
that interacts with Tat protein to regulate viral transcrip-
tion [135]. TAR has been shown to negatively regulate
translation by at least two mechanisms: i) inhibition of
scanning ribosomes on HIV-1 mRNA [16-18], and ii) acti-
vation of the interferon-induced serine/threonine protein
kinase R (PKR) when at a low concentration [136]. Active
PKR is composed of two N-terminal double-stranded RNA
binding motifs (dsRBM) and a C-terminal kinase domain.
The intra-molecular interaction between the dsRBM and
kinase domain form an inactive "closed" conformation
(Figure 2) [137,138]. A change to an "open" conforma-
tion is triggered by association of PKR with double-
stranded RNA (including HIV-1 TAR), leading to PKR
dimerization and autophosphorylation [139-141]. In its
active form, PKR phosphorylates Ser-51 on the α subunit
of eukaryotic initiation factor 2 (eIF2α), which blocks
eIF2α activation of the guanine exchange factor eIF2B (for
a general review, see [142]). The disruption of eIF2α func-
tion by PKR ultimately reduces global cellular translation.
HIV-1 is among a variety of eukaryotic viruses that have
evolved to circumvent this cellular defense mechanism.
Roy and colleagues found that although low levels of TAR
RNA bind and activate PKR [136], productive HIV-1 infec-
tion causes a decrease in PKR protein levels [143]. A sepa-
rate study indicated that a high concentration of TAR-
containing RNA can inhibit PKR activation, possibly by
sequestration of the protein [144]. The double-stranded
nature of the HTLV-1 Rex response element (RxRE)
inflicted a similar fate for PKR, affecting PKR autophos-Retrovirology 2009, 6:8 http://www.retrovirology.com/content/6/1/8
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HIV-1 modulates the interferon-induced antiviral host mechanisms, protein kinase R and 2',5'-oligoadenylate synthesis Figure 2
HIV-1 modulates the interferon-induced antiviral host mechanisms, protein kinase R and 2',5'-oligoadenylate 
synthesis. Structure in blue represents generic retrovirus transcript with highly structured 5' UTR. Left panel illustrates the 
2',5'-oligoadenylate synthesis (2-5OAS) pathway that typically results in RNAseL activation and cleavage of viral double-
stranded RNA. Vertical lines within RNaseL indicate ankyrin repeats. Right panel illustrates the double-stranded RNA-inducible 
PKR pathway. PKR is depicted by the green N-terminal double-stranded RNA binding motif (dsRBM) with central domain and 
C-terminal kinase domain depicted by pink line. Tat transactivation response element (TAR) RNA binding protein (TRBP), Tat, 
and 2-5OAS proteins are marked. Tat 86 and Tat 72 indicate the 86 amino acid and 72 amino acid isoforms of HIV-1 Tat. Cir-
cles labeled with P indicate phosphorylation. Black arrows indicate normal progression through the pathway. Red block arrows 
and text boxes outlined in red indicate points of interaction and modulation by HIV-1.Retrovirology 2009, 6:8 http://www.retrovirology.com/content/6/1/8
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phorylation that diminished with increasing concentra-
tion of RxRE-containing RNA [145].
The reduction in PKR activity observed by Roy and col-
leagues occurred with both HIV-1 infection and expres-
sion of HIV-1 Tat alone, implicating Tat as a major
contributor to the downregulation [143]. The action of
Tat was specific to PKR, since another interferon-response
pathway, 2',5'-oligoadenylate synthesis (2-5OAS), was
not affected by Tat alone. Later in vitro work identified the
basic region of Tat as a substrate of PKR, and found that
Tat can compete with eIF2α for phosphorylation [146].
Pre-incubation of PKR with increasing concentrations of
Tat protein in in vitro kinase assays showed that Tat effec-
tively reduced autophosphorylation of PKR in response to
dsRNA. This study indicated that both the one exon (Tat
72) and two exon (Tat 86) variants of Tat were phosphor-
ylation substrates of PKR (72 and 86 refer to predicted Tat
proteins in their amino acid lengths). McMillan and col-
leagues found that only Tat 86 could be phosphorylated
by pre-activated PKR although both Tat variants interacted
with PKR [147]. While Tat 72 was not a phosphorylation
substrate for PKR, in vitro pulldown and kinase assays
indicated that Tat 72 binds to PKR and acutely inhibits its
autophosphorylation and its ability to phosphorylate Tat
86. In vivo interaction between PKR and Tat 72 was veri-
fied in both a HeLa cell line and an in HIV-1 infected T
cells. Overexposure of immunoblots indicated a low, yet
detectable interaction between PKR and Tat 86, consistent
with Tat 86 being a substrate of PKR. Although not dem-
onstrated, it seems likely that the interactions between
PKR and Tat variants occur in the context of TAR RNA due
to their shared ability to bind TAR. Separate work has
determined that phosphorylation of Tat 86 by PKR
increases its interaction with TAR RNA and triggers more
robust transcription of viral RNA [148]. An intriguing pos-
sibility is that the Tat variants are temporally controlled
during the HIV-1 lifecycle to strategically modulate viral
protein production. Overall, the analyses of HIV-1/PKR
interplay indicate that although the HIV-1 TAR structure
should elicit activation of the PKR antiviral defense
(which it does at low concentration), Tat uses two strate-
gies to combat this action: blocking the autophosphoryla-
tion of PKR; or acting as a substrate competitor to reduce
the level of phosphorylated eIF2α thereby altering global
translation. An overview of HIV-1/PKR interplay is
depicted in Figure 2.
An additional strategy to counter innate defense is the
HIV-1 interaction with a cellular double-stranded RNA
binding protein, TAR RNA binding protein (TRBP) (Table
2) [149]. TRBP (also designated TRBP1) was discovered to
bind HIV-1 TAR in a cDNA screen in HeLa cells [149]. An
isoform designated TRBP2 has been identified that
includes a 21 amino acid extension at the N-terminus
[150]. Because both TRBP isoforms have been reported to
activate the HIV-1 LTR in human and murine cells, they
appear to be functionally equivalent [151].
TRBP proteins facilitate HIV-1 production through at least
two mechanisms: i) potently inhibiting interferon-α
induced PKR autophosphorylation through a direct pro-
tein:protein interaction [152]; and ii) binding to HIV-1
TAR and Rev response element (RRE) RNA resulting in
enhanced virus expression [149]. A protective activity of
TRBP on HIV-1 was demonstrated by Benkirane et al.,
who found that CEM T cells infected with HIV-1 express-
ing TRBP1 were resistant to the antiviral effect of inter-
feron-α treatment [152]. Interferon-α repression of HIV-1
replication is due largely to PKR activation; therefore, a
role for TRBP proteins in the PKR pathway was investi-
gated. Stable expression of TRBP1 in HeLa cells reduced
phosphorylation of PKR in response to interferon-α. Co-
immunoprecipitation assays indicated an RNA-independ-
ent interaction between TRBP1 and PKR; however, treat-
ment with interferon-α reduced this interaction in a dose-
dependent manner. Immunoblotting revealed that INF-α
inversely affected steady-state levels of PKR (increased)
and TRBP1 (decreased) proteins, which could explain the
apparent reduction in protein-protein association. Sepa-
rate studies have reported that HIV-1 infection reduces the
production of interferon-α, -β, and -γ in both T cells and
monocytes, which could be a cause for the correlated
reduction of PKR activation in response to HIV-1 [153-
155]. These strategic observations illuminate the vast web
of interactions that HIV-1 can balance to sustain produc-
tive virus replication (Figure 2).
TRBP proteins directly modulate retrovirus translation
Structural features of TAR RNA reduce the translation effi-
ciency of heterologous reporter mRNAs, and the introduc-
tion of point mutations that reduce the free energy of TAR
restores translation of a TAR-CAT reporter RNA in vitro
[17,156]. Addition of TRBP1 purified from E. coli caused
a significant increase in translation of wild-type TAR-CAT
RNA. Interestingly, both CAT and TAR-CAT RNAs elicited
activation of PKR, as evidenced by the phosphorylation of
eIF2α. This result suggested that the reduced translation of
TAR-CAT mRNA and the subsequent rescue by TRBP1 was
at least in part independent of a PKR-specific effect. Con-
sistent with this idea, low concentrations of TRBP2 facili-
tated translation of TAR-Luciferase mRNA in transiently
transfected PKR-deficient mouse embryonic fibroblasts
[156]. Importantly, this experiment demonstrated that
both TRBP1 and TRBP2 isoforms can impact the transla-
tion of TAR-containing RNAs. Experiments with truncated
domains of TRBP2 showed that the double-stranded RNA
binding domains singly or in combination were responsi-
ble for the stimulatory effect on reporter protein produc-
tion. A comparison of reporter protein and mRNA levelsRetrovirology 2009, 6:8 http://www.retrovirology.com/content/6/1/8
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showed that the effect induced by the TRBP proteins was
attributable to increased translation and not increased
steady-state mRNA levels. Taken together, these results
provide an example of how HIV-1 RNA has evolved to uti-
lize cellular proteins to boost translation (Table 2). A
growing list of roles have been identified for TRBP pro-
teins, including a key role in the small RNA pathway in a
ribonucleoprotein complex with siRNA, Dicer, and Ago2
[157,158]. This and additional implications of TRBP
activities on HIV-1 replication are discussed below and
reviewed elsewhere [159].
HIV-1 versus the 2'–5' oligoadenylate pathway
Studies of infected patients have indicated that HIV-1
affects 2'–5' oligoadenylate synthetase (2-5OAS) (Figure
2), which is a key enzyme in the regulation of an addi-
tional interferon-induced antiviral defense. 2-5OAS binds
dsRNA longer than 60 bases through its amino-terminal
residues. This triggers 2-5OAS to synthesize 2',5'-oligoad-
enylate (2-5A), a small molecule that binds to ankyrin
repeats in the enzyme RNaseL and causes its dimerization
and activation [160,161]. Once activated, RNaseL cleaves
viral dsRNA with the mission of blocking viral protein
production. Multiple viruses, including HIV-1, have
devised a strategy to cripple this host defense to promote
virus survival [162-164]. Association of HIV-1 RNA with
2-5OAS was investigated by SenGupta and Silverman,
who incubated affinity resins bound to either HIV-1 5'
UTR RNA or poly r(I):r(C) with extracts of interferon-
treated HeLa cells prior to activation of 2-5A synthesis by
magnesium and ATP. Both RNAs bound 2-5OAS; how-
ever, 2-5A synthesis was lower by a factor of five in
response to the HIV-1 RNA substrate [165]. A similar
study found that in vitro transcribed HTLV-1 RxRE RNA
stimulated 2-5A synthesis from both interferon-treated
HeLa cells and assays that used purified 2-5OAS [145].
The level of 2-5A production in response to RxRE RNA
was similar to that induced by TAR RNA, although poly
r(I):r(C) RNA induced 2-5A synthesis more potently than
either RxRE or TAR. The authors suggested that the
increased ability of poly r(I):r(C) to induce 2-5A produc-
tion relates to the vast size difference of the molecule com-
pared to RxRE or TAR RNA; this size difference increases
the interaction between 2-5OAS and dsRNA.
Although structures in the retroviral genome apparently
trigger activation of the 2-5OAS pathway, the virus may
stop RNA degradation at a later stage in the signaling cas-
cade. In support of this idea, a 65% reduction in the bind-
ing affinity of 2-5A to RNase L was observed in
lymphocytes of HIV-1-infected patients [153-155,166].
Conversely, recent work has found that activation of 2-5A
activity can combat HIV-1 replication [167]. Homan and
colleagues utilized a stable 2-5A agonist called 2-5AN6B,
which is taken up into the cytoplasm of cultured T cells
and subsequently activates RNaseL [167]. They found that
treatment of PBMCs with 2-5AN6B inhibited the genera-
tion of infectious HIV-1, increased the expression of inter-
feron-α and -γ, and increased the expression of
chemokines. Later work showed that 2-5AN6B caused a sig-
nificant decrease in HIV-1 Gag protein production at 96
hours post-infection of CD4+ lymphocytes cultured from
healthy donors. This decrease also was observed in the
supernatant of CD4+ and CD14+ cells isolated from HIV-
1 seropositive patients [168]. Taken together, these results
indicate that HIV-1 targets both the PKR and 2-5OAS anti-
viral pathways to protect viral RNA from degradation,
which ultimately protects translation and the production
of virus particles.
Retrovirus interplay with the small RNA pathway
The small RNA pathway operates a versatile innate antivi-
ral defense, and retroviruses are likely to exploit some
aspect of this antiviral defense [169]. MicroRNAs (miR-
NAs) are short non-coding regulatory RNAs (~21 to 25
nucleotides) expressed by viral genomes and their eukary-
otic host [170,171]. The interaction of endogenously
expressed miRNAs with distinct targeted mRNA potently
down-regulates gene expression by triggering specific deg-
radation or translational inhibition of the transcript. miR-
NAs have the potential to abrogate the deleterious effects
of human retrovirus infection or at least slow disease pro-
gression [172-174]. While details of interplay between
plant viruses and host RNA silencing are robust, details of
retrovirus interplay with host RNA silencing are just
beginning to develop.
Early evidence of host miRNA activity in retrovirus infec-
tion emerged from the finding that miR-32 downregu-
lated primate foamy virus type 1 in human cells [170].
This study also identified that the PFV-1 Tas protein can
act as an RNA silencing suppressor (RSS). RSSs play a well-
described role in the pathogenesis of plant viruses, but
remain a controversial phenomenon for animal viruses
[175]. Interestingly, Tas RSS activity is recapitulated across
the plant and animal kingdoms [170].
A role for RNA silencing in HIV-1 replication kinetics has
been documented in both peripheral blood mononuclear
cells [173] and in resting primary CD4+ T cells [174].
Mechanistically, host RNA silencing inhibits translation
of HIV-1 gag-pol mRNA and possibly all HIV-1 transcripts
[176]. This activity occurs independently of a change in
steady state gag-pol mRNA and reflects an anti-viral activ-
ity of the host cell miRNAs. An examination of the 3' UTR
of HIV-1 transcripts from several strains has identified
binding sites for a cluster of cellular miRNAs [174]. The
identified miRNAs are enriched in resting CD4+ T cells
compared to activated CD4+ T cells. Inhibition of these
miRNAs correlated with increased viral protein produc-Retrovirology 2009, 6:8 http://www.retrovirology.com/content/6/1/8
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tion and virus particle production in resting CD4+ T cells
without altering the amount of spliced or unspliced HIV-
1 mRNA. These results unveiled an important role for cel-
lular miRNAs in HIV-1 latency.
HIV-1 has been shown to utilize several strategies to coun-
ter host RNA silencing: suppression, protection of viral
RNA in viral nucleocapsid, evasion, modulation and
adaptation to RNA silencing [177]. Suppression of
miRNA-directed activity against HIV-1 was first docu-
mented by Bennasser et al. [178], but remains controver-
sial [179]. Tat RSS activity is modest and not global, and
is demonstrated in several [176,178] but not all assays
[179]. Tat RSS activity is dependent on the double-
stranded RNA binding domain [178], which is a feature
conserved in many plant virus RSS [175]. Like PFV-1 Tas,
HIV-1 Tat displays cross-kingdom RSS activity [176].
Multiple lines of evidence indicate a physiological role for
RSS activity in productive expression of the HIV-1 provi-
rus. First, downregulation of Dicer and/or Drosha, which
suppressed the small RNA pathway, enhanced HIV-1 rep-
lication kinetics in chronically infected human PBMC and
Jurkat T cells [173]. Second, plant virus RSS [176] or Ebola
V35 [180] can replace the Tat RSS activity. Third, the atten-
uation in gag mRNA translation by RNA silencing is exac-
erbated by the K51A substitution in the Tat double-
stranded RNA-binding domain [176,178]. Finally, when
Dicer was down-regulated, this change rescued robust gag
translation and bolstered HIV-1 virion production in a
continuous cell line [176].
Additional evidence for HIV-1 modulation of the host
small RNA pathway has been presented by Jeang and col-
leagues [158]. This study found that TAR:TRBP interaction
effectively sequestered TRBP from Dicer. The outcome was
a reduction in the processing of reporter shRNA (luci-
ferase) and three endogenous pre-miRNAs (miR-16, miR-
93, and miR-221) that are downregulated by HIV-1 [181].
The implicit consequence of TRBP sequestration by TAR is
less TRBP is available to interact with Dicer and assist in
loading of guide-strand miRNA into the RISC complex
[158,182]. Taken together with the identification of Tat
RSS activity, the results indicate redundant strategies oper-
ated by TAR RNA and Tat RSS protein temper host RNA
silencing of HIV-1 gene expression.
In sum, the small RNA pathway represents yet another
host post-transcriptional mechanism that the retrovirus
leverages to its benefit. An interesting notion is that tissue-
specific miRNAs may influence retrovirus evolution
[183].
Perspectives
In conclusion, investigations continue to unveil retrovi-
rus-host interplay in post-transcriptional control. A recur-
rent theme is employment of viral strategies that leverage
antiviral defenses to achieve balanced viral gene expres-
sion. The fundamental knowledge of retrovirus transla-
tional control continues to expand. Each new finding has
potential utility to devising new strategies for antiviral
therapy and improving retroviral vector transduction. A
common theme of retrovirus translational control is that
an RNA structural motif interacts with viral or cellular pro-
tein to modulate balanced levels of structural and enzy-
matic proteins necessary for viral replication
(summarized in Tables 1 and 2). These RNA-protein inter-
actions have already been employed to improve gene
transfer vectors [184-186]. Further understanding of these
RNA-protein interactions may ultimately generate special-
ized vectors or helper virus cassettes that modulate inter-
actions with translation modulatory proteins, such as
RNA helicase A, 9G8, or hnRNP E1, or other yet-to-be
identified interaction partners.
Another significant arena is the understanding of viral
proteins that alter cellular post-transcriptional innate
defenses (summarized in Figure 2 and Table 2). A protein
of obvious importance is HIV-1 Tat, which in addition to
its essential role in virus-specific transcription, has the
ability to block the antiviral PKR response and act as an
RNA silencing suppressor. Given its multi-faceted activity,
Tat could be a sophisticated target for antiviral therapy.
The other HIV-1 regulatory protein Rev has already been
targeted in clinical trial [187], but this approach to influ-
encing viral translational control remains to be realized.
Decoding the molecular mechanisms of retrovirus transla-
tional control is valuable to fundamental knowledge and
to the development of targeted antiviral strategies and
gene transfer tools.
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